MECHANO-AI Ai-powered Prediction of Cancer Therapy Response Using Ultrasound Shear Wave Elastography
- Coordinator
- AnaBioSi-Data Ltd, Cyprus
- Runs
- 1 August 2026 to 31 July 2028
- Status
- Running
- EU funding
- €328k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101308593
What the project is doing
In the project's own words, from its summary on CORDIS.
PROGNOS-AI aims to revolutionize cancer therapy selection by introducing an AI-driven platform that predicts patient response before treatment begins, using the mechanical properties of tumors as a novel prognostic biomarker. Despite major advances in oncology, up to 60 % of patients still receive ineffective therapies due to the biological and mechanical heterogeneity of tumors. Tumor stiffness—measurable non-invasively through Shear Wave Elastography (SWE)—has emerged as a powerful indicator of therapeutic outcome.
Building on AnaBioSi-Data’s pre-clinical discoveries (> 1,300 tumor datasets, > 88 % accuracy), PROGNOS-AI transforms these findings into a clinically validated decision-support tool. The project combines SWE imaging, advanced deep-learning algorithms, and explainable-AI modules to quantify tumor stiffness maps and forecast therapy response. A multi-centre validation involving the German Oncology Center (CY), University of Crete (GR) and Kliniken Essen-Mitte (DE) will enrol 400 breast-cancer pat
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| AnaBioSi-Data Ltd | Nicosia | Cyprus | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI